Home>Topics>Stocks>Guidant Corporation

Guidant Corporation

  1. All
  2. Commentary
  3. Headlines
  1. Boston Scientific's Guidant Acquisition Led To Fines, Settlements And Penalties; But That's Just The Beginning Of Its Woes

    Headlines

    Fri, 2 Mar 2012

    history dates to the 1960s, its 2006 acquisition of Guidant Corporation made it one of the world's largest cardiovascular ..... relevant to its continuing business lines. While the Guidant acquisition has strengthened the company's product

  2. Words’ Worth

    Headlines

    Fri, 27 May 2011

    Guidant 's GDT third-quarter performance was a mixed ..... another quarter's worth of cash flows. Guidant weathered another quarter of steep declines ..... year, as the worst is nearly over. Guidant 's moderately strong implantable cardioverter

  3. Medtronic Drops the Ball on Pacemakers

    Headlines

    Fri, 21 Jan 2011

    I have a pacemaker. I have always used Medtronic ( MDT ) or Guidant ( GDT ) devices in the past. In 2005, biventricular pacing, aka cardiac resyncronization therapy (CRT), was a new and somewhat

  4. Boston Set to Close Guidant Deal

    Commentary

    Thu, 20 Apr 2006

    from U.S. regulators to proceed with the acquisition of Guidant GDT . Boston had already obtained the necessary antitrust clearances ..... to satisfy the Food and Drug Administration, recover from Guidant 's spate of product recalls last year, and prepare for the

  5. St. Jude Lowers 1Q Forecast

    Commentary

    Thu, 6 Apr 2006

    did a great job taking share as rival Guidant GDT struggled with product recalls last summer ..... continue into 2006. By the fourth quarter, Guidant had already seen its share losses stabilize ..... the cusp of wrapping up its purchase of Guidant , we believe Boston will treat its newly

  6. Management Changes at Abbott

    Commentary

    Wed, 22 Mar 2006

    division. Abbott has been increasing its investments in medical products, with work on carotid and coronary stents over the past several years and its proposed purchase of Guidant 's GDT vascular medical-device business for $4.1 billion.

  7. St. Jude Sees More ICD Potential

    Commentary

    Wed, 15 Mar 2006

    standing behind our fair value estimate of $43 per share. Like competitor Medtronic MDT, St. Jude pressed its advantage as Guidant GDT tried to recover from its product-recall stumbles over the summer. St. Jude has done an impressive job building up market

  8. Medtronic Remains Steady in 3Q

    Commentary

    Mon, 13 Mar 2006

    cardioverter defibrillators (ICDs) and spinal products. As Guidant GDT continued to recover from its series of ICD recalls, Medtronic ..... gains. With Boston Scientific's BSX pending purchase of Guidant , we expect it may take the rest of 2006 for this key competitor

  9. Morningstar's 2006 Contrarian Portfolio--Part 2

    Headlines

    Mon, 27 Feb 2006

    Pharmaceuticals MLNM 295 133.42 Centex CTX 298 117.54 Capital One Financial COF 63 106.74 Countrywide Financial CFC 252 97.41 Guidant GDT 244 96.11 Ann Taylor Stores ANN 1,076 90.99 Jack Henry JKHY 331 72.51 Avg (equally weighted) 360 142.61 S&P

  10. Buy J&J and Avoid the Winner's Curse

    Headlines

    Mon, 6 Feb 2006

    Johnson & Johnson JNJ for control of Guidant GDT . It's a striking example of how the ..... Everything Has Its Price Sure, a J&J/ Guidant combo would have been a powerhouse ..... the kind of manufacturing problems that Guidant has been suffering. But Johnson & Johnson

« Prev12345Next »
Content Partners